Safety and Efficacy of Serplulimab Combined with Neoadjuvant Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer: A Retrospective Study

Meng Tian,1,2,&ast; Minghui Zhao,2,&ast; Linhong Jiang,2,&ast; Jia Liu,2,&ast; Gefenqiang Shen,2 Zhaoyue Zhang,2,3 Caiqiang Zhu,1 Sheng Zhang,2 Xinchen Sun,2 Yujing Shi,1 Xiaoke Di1,2 1Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, People’s Repub...

Cijeli opis

Spremljeno u:

Bibliografski detalji
Glavni autori:	Tian M, Zhao M, Jiang L, Liu J, Shen G, Zhang Z, Zhu C, Zhang S, Sun X, Shi Y, Di X
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2025-11-01
Serija:	Cancer Management and Research
Teme:	locally advanced rectal cancer neoadjuvant chemoradiotherapy Serplulimab neoadjuvant immunotherapy pathological complete response
Online pristup:	https://www.dovepress.com/safety-and-efficacy-of-serplulimab-combined-with-neoadjuvant-chemoradi-peer-reviewed-fulltext-article-CMAR
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Safety and Efficacy of Serplulimab Combined with Neoadjuvant Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer: A Retrospective Study

Slični predmeti